BioNano Genomics, Inc. WT EXP 082123 (BNGOW) Stock Overview
Explore BioNano Genomics, Inc. WT EXP 082123’s financial performance, market position, analyst ratings, and future outlook.
BioNano Genomics, Inc. WT EXP 082123 (BNGOW)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-0.18
EPS (TTM)
N/A
ROE
-0.71%
BNGOW Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, BioNano Genomics, Inc. WT EXP 082123's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BNGOW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind BioNano Genomics, Inc. WT EXP 082123's NASDAQ-traded stock include a P/E ratio of -0.18 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of BNGOW on the NASDAQ.